Hologic Inc. News
Stock Market Today: S&P, Dow, Nasdaq hit new highs to end week
Despite limited economic data and earnings today, momentum builds, especially in some speculative stocks.
Midday stock movers: Palantir, Boeing, Trump Media
Here are the stocks making the biggest market moves midday.
Victoria's Secret Among Bank of America Diversity-Stock Picks
'Several diversity, equity, and inclusion demographic factors already impact the global economy,' Bank of America analysts say.
David and Goliath: Cramer's 'Mad Money' Recap (Wednesday 2/3/21)
Jim Cramer says before you join the trading revolution, put down the slingshot and pick up the annual report. Here are his 7 tenets of smart trading.
Hologic Rises on Higher Profit Forecast, $1 Billion Buyback
Hologic lifted its first-quarter-profit forecast after selling 30 million coronavirus tests. The stock is higher.
Stick With Stocks: Cramer's 'Mad Money' Recap (Thursday 11/5/20)
It used to be bonds vs. stocks, Jim Cramer says, but now the tables have turned.
Hologic Gets FDA Authorization for Asymptomatic Covid Test
Hologic's coronavirus test for asymptomatic subjects has received emergency use authorization from the Food and Drug Administration.
Quest Diagnostics Furloughs Staff and Makes Other Cost Cuts
Quest Diagnostics, one of the companies that make coronavirus-testing kits, is making a series of cost cuts, including staff furloughs and executive-pay cuts.
Coronavirus Latest Updates: A Timeline of Recent Events
Here is TheStreet's latest news on the coronavirus and its worldwide and economic impact, and a timeline of events since January
Hologic Ramps Up Coronavirus Test Kit Production
Hologic CEO says coronavirus test kits are being shipped out, with more to come.
Hologic Rises After Dumping Medical Aesthetics Business
The decision to sell comes two years after Hologic bought Cynosure for $1.65 billion, with the medical aesthetics company having 'significantly underperformed our expectations,' says Hologic.
Trade Noose Tightens: Cramer's 'Mad Money' Recap
Jim Cramer puts the new tariffs in context and tells investors how to survive the trade war: Stand by some techs, and companies without China exposure.
What to Watch Out For: Cramer's 'Mad Money' Recap
Jim Cramer says that although a sell-off can breed a buying opportunity, investors need to worry about sky-high IPOs and other signs of froth.
Bring On the Bitcoin Futures Trading Insanity!
Bitcoin futures trading kicks off on Sunday. You ready? Do you even care? Hey, the worst thing that could happen is that the avalanche of millionaires chasing bitcoin is so great the internet shuts down for hours.
How to Buy Great, Cheap Stocks When Indexes Are at All-Time Highs
As the market keeps reaching all-time highs, the mantra of 'buying low, sell high' isn't always that easy. Here's how to strategize.
Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls
American Water Works leads the S&P 500 for the most female representation on its board. But, there are still a handful of companies without any female directors.
Biotech Movers: Merck Up on Approval for Keytruda/Chemo Combo
The approval marks the first time that an immunotherapy has been combined with another drug to kill cancer cells more effectively.
Cramer: These Sectors Look Bullish (Part III)
From Abbott Labs to Wynn, these names rate checking out.
Cramer: These Stocks Look Like 'Easy Pickings'
From Aetna to United Technologies, these names are hot.
Hologic Inc. News from TheStreet Pro
Trump’s Fannie Mae, Freddie Mac Plan Could Boost These Two Big Bank Names
Why we may need to raise our price targets for these two holdings again.
Hologic's Charts Are Looking a Little 'Touch and Go'
For now it looks like HOLX will try to move higher.
Jim Cramer: It's Time for Clear COVID Rules That Make Sense
Outside of the pro sports world, it seems like amateur hour with regard to protocols.
Updating Duck Creek Technologies, One of Our 2 Picks for 2021
$60 is our Point and Figure target so far.
Hologic Continues to Point Up, but Buyers Should Be Patient
It might be best to wait for a pullback in shares of the diagnostic and testing company before buying.
Redemption Is in Order: My Individual Stock Picks for 2021
Two intriguing names are my choices for the year ahead.
Here's My Sentiment on ... Sentiment
Let's look at how the intermediate-term sentiment gauges have not shown much panic.
Jim Cramer: 20 Stocks That Are Emblematic of What's Driving the Market
This list is not a buy list but a list of stocks that have been brought to new heights.
Hologic's Charts and New Quant Rating Make It an Attractive Long Idea
Let's see if the two are in alignment.
2 Stocks You Really Should Consider Shorting This Week
These 'bearish bets' are showing both technical and quantitative deterioration.
Hologic Looks Good as Long as the Stock Doesn't Close Below This Key Level
Let's check out the charts and indicators of this medical equipment maker.
4 Bargain-Priced Names for the Second Half
FireEye, Achaogen, Hologic and LGI Homes present attractive values in a challenging market.
Insider Buying Alerted Me to These Stocks
I have often found that insider buying in small- and mid-cap stocks can be a huge 'tell'.
Six Off the Beaten Path Healthcare Stock Gems
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
Cramer: There Are Powerful Themes in Several Bull Markets
It's a wonder to me how split this market really is.
3 Charts Are Bullish on Hologic, So What Does That Tell You?
Stock is set to break out to the upside
Breaking News
Goldman Sachs analyst revisits Rivian stock price target after Q4 earnings
Rivian's R2 SUV, which is expected to challenge Tesla's Model Y, will launch early next year.
Goldman Sachs issues surprising gold price target for 2025
The investment firm's analysts share their views about the precious metal.
UnitedHealth stock plunges on report of DoJ Medicare Advantage probe
UnitedHealth, still reeling from the murder of one of its top executives, is reportedly facing a Department of Justice investigation.
IRS makes a startling change that could impact tax returns
The federal agency has opted to make a drastic decision during a critical time of the year.










































